Clinical studies recruiting near Dothan

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Phase 3 · Vanda Investigational Site · Vanda Pharmaceuticals · NCT06953869 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0054 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Phase 3 · Digestive Health Specialists of the Southeast · Janssen Research & Development, LLC · NCT07499232 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcera
Phase 3 · Digestive Health Specialists · Eli Lilly and Company · NCT06937086 Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I
Phase 3 · Alkermes Investigator Site · Alkermes, Inc. · NCT05303064 A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Live
Phase 1 · Dothan · Bayer · NCT06764316 A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · Digestive Health Specialsits · Takeda · NCT06095128 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06528314 ALTO-207 in Adults With Treatment-resistant Depression (TRD)
Phase 2 · Site 7173 · Alto Neuroscience · NCT07553637 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · Harmonex Neuroscience Research · Intra-Cellular Therapies, Inc. · NCT06372964 A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Dep
Phase 2 · Harmonex /ID# 277517 · AbbVie · NCT07276997 Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Ob
Phase 3 · Digestive Health Specialists · Eli Lilly and Company · NCT06937099 A Study of VERVE-102 in Patients With Familial Hypercholesterolemia or Premature Coronary Artery Disease
Phase 1 · Clinical Study Center · Verve Therapeutics, Inc. · NCT06164730 A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD
Phase 3 · SEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS · Hoffmann-La Roche · NCT05878769 Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial
NA · Trinity Research Group · Sonavex, Inc. · NCT06190717 Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is
Phase 3 · SEC Clinical Research · Regeneron Pharmaceuticals · NCT07430956 Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatri
Phase 3 · Harmonex Neuroscience Research · Intra-Cellular Therapies, Inc. · NCT06690398 A Study to Assess the Efficacy and Safety of Solriamfetol in Children With ADHD
Phase 3 · Clinical Research Site · Axsome Therapeutics, Inc. · NCT07717879 BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
Phase 3 · SEC Clinical Research · Pfizer · NCT07160244 A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
Phase 3 · Harmonex Neuroscience Research · Xenon Pharmaceuticals Inc. · NCT07076407 AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
Phase 3 · Research Site · AstraZeneca · NCT07611110 Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Phase 2 · SEC Clinical Research · Regeneron Pharmaceuticals · NCT07175428 A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Phase 2 · Glaukos Investigative Site · Glaukos Corporation · NCT05966493 A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
Phase 3 · Research Site · AstraZeneca · NCT05774951 Pivotal Study of the Velocity™ pAVF System
NA · Trinity Research Group · Venova Medical · NCT07153939 A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction
Phase 3 · Akero Clinical Study Site · Akero Therapeutics, Inc · NCT06215716 Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
Phase 2 · Digestive Health Specialists /ID# 266216 · AbbVie · NCT06548542 WRAP North America
Phase N/A · Trinity Research Group · Merit Medical Systems, Inc. · NCT06807099 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · Research Site · AstraZeneca · NCT07000357

Look up another city

Look up another condition